Coprescription of mood stabilizers in schizophrenia, dosing, and clinical correlates: An international study
Year: 2020
Type: article
Study design: Observational Study
DOI: 10.1002/hup.2752
Authors: Wai Kwong Lim, Qian Hui Chew, Yan‐Ling He, Tian‐Mei Si, Fung‐Kum Helen Chiu, Yu‐Tao Xiang, Takahiro A. Kato, Shigenobu Kanba, Naotaka Shinfuku, Min‐Soo Lee, Seon‐Cheol Park, Yong‐Chon Park, Mian‐Yoon Chong, Shih‐Ku Lin, Shu‐Yu Yang, Adarsh Tripathi, Ajit Avasthi, Sandeep Grover, Roy Abraham Kallivayalil, Pichet Udomratn, Kok Yoon Chee, Andi J. Tanra, Md Golam Rabbani, Afzal Javed, Samudra Kathiarachchi, Dulshika Waas, Wing Aung Myint, Norman Sartorius, Van Cuong Tran, Kim Viet Nguyen, Chay‐Hoon Tan, Ross J. Baldessarini, Kang Sim
Institutions: Institute of Mental Health, Shanghai Mental Health Center, Peking University, Chinese University of Hong Kong, University of Macau, Kyushu University, Kobe University, Korea University, Inje University Haeundae Paik Hospital, Hanyang University, Chang Gung University, Kaohsiung Chang Gung Memorial Hospital, Taipei Municipal YangMing Hospital, Taipei City Hospital, King George's Medical University, Post Graduate Institute of Medical Education and Research, Pushpagiri Medical College, Prince of Songkla University, Universiti Tunku Abdul Rahman, Hasanuddin University, University of Sri Jayewardenepura, Myanmar Medical Association, National University Hospital, McLean Hospital
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3046847196
